medigraphic.com
ISSN 0185-3325 (Impreso)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2014, Número 5

<< Anterior Siguiente >>

Salud Mental 2014; 37 (5)


Evaluación de la depresión en pacientes con cáncer terminal y su aplicación en el contexto mexicano: Una revisión

Landa-Ramírez E, Cárdenas-López G, GJ, Sánchez-Román S, Riveros-Rosas A

Idioma: Español
Referencias bibliográficas: 47
Paginas: 415-422
Archivo PDF: 289.01 Kb.


RESUMEN

La depresión es uno de los problemas emocionales más frecuentes en pacientes con cáncer terminal. Debido a la evolución de la enfermedad, varios síntomas físicos presentes en los pacientes se pueden yuxtaponer y confundir con los síntomas que permiten identificar de manera taxonómica la depresión, lo cual dificulta la evaluación del problema. El objetivo de este artículo es realizar una revisión de los principales instrumentos utilizados para evaluar la depresión en pacientes con cáncer terminal, junto con sus implicaciones en el contexto mexicano. Con base en la información recabada se puede decir que es más pertinente realizar una evaluación de la depresión enfocada en los aspectos emocionales que en los somáticos. Actualmente existe una gran cantidad de instrumentos para evaluar la depresión que dan mayor énfasis a los aspectos de la anhedonia y las emociones que a los aspectos somáticos de la depresión. En México existe un enorme rezago en el desarrollo de instrumentos que permitan identificar estos síntomas. Se concluye señalando instrumentos alternativos para evaluar la depresión en pacientes con cáncer terminal, estos instrumentos podrían ser evaluados y considerados en un futuro en el contexto de la medicina paliativa.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Teunissen SC, Wesker W, Kruitwagen C, de Haes HC et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 2007;34:94-104.

  2. Laugsand EA, Kaasa S, de Conno F, Hanks G et al. Research Steering Committee of the EAPC. Intensity and treatment of symptoms in 3030 palliative care patients: a cross-sectional survey of the EAPC Research Network. J Opioid Manag 2009;5:11-21.

  3. Mitchell AJ, Chan M, Bhatti H, Halton M et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011;12(2):160-74. doi: 10.1016/S1470-2045(11)70002- X. Epub 2011 Jan 19.

  4. Hotopf M, Chidgey J, Addington-Hall J, Ly KL. Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med 2002;16(2):81-97.

  5. Wasteson E, Brenne E, Higginson IJ, Hotopf M et al. European Palliative Care Research Collaborative (EPCRC). Depression assessment and classification in palliative cancer patients: a systematic literature review. Palliat Med 2009; 23:739-53. doi: 10.1177/0269216309106978.

  6. Lloyd-Williams M, Dennis M, Taylor F. A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliat Med 2004;18:558-563.

  7. Delgado-Guay M, Parsons HA, Li Z, Palmer JL. Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer. 2009 may;17(5):573-579. doi: 10.1007/ s00520-008-0529-7.

  8. Teunissen SC, de Graeff A, Voest EE, de Haes JC. Are anxiety and depressed mood related to physical symptom burden? A study in hospitalized advanced cancer patients. Palliat Med 2007;21:341-346.

  9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM IV, fourth edition. Washington DC: APA; 1994.

  10. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.

  11. Rayner L, Price A, Hotopf M, Higginson IJ. The development of evidence- based European guidelines on the management of depression in palliative cancer care. Eur J Cancer 2011;47:702-12. doi: 10.1016/ j.ejca.2010.11.027.

  12. Vodermaier A, Linden W, Siu C. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 2009;101:1464-88. doi: 10.1093/jnci/djp336.

  13. Mitchell AJ, Kaar S, Coggan C, Herdman J. Acceptability of common screening methods used to detect distress and related mood disorderspreferences of cancer specialists and non-specialists. Psychooncology 2008;17(3):226-236.

  14. Mitchell AJ. Are one or two simple questions sufficient to detect depression in cancer and palliative care? A Bayesian meta-analysis. Br J Cancer 2008;98:1934-43, doi: 10.1038/sj.bjc.6604396.

  15. Akechi T, Okuyama T, Sugawara Y, Shima Y et al. Screening for depression in terminally ill cancer patients in Japan. J Pain Symptom Manage 2006;31:5-12.

  16. Akizuki N, Akechi T, Nakanishi T, Yoshikawa E et al. Development of a brief screening interview for adjustment disorders and major depression in patients with cancer. Cancer 2003;97:2605-2613.

  17. Chochinov HM, Wilson KG, Enns M, Lander S. “Are you depressed?” Screening for depression in the terminally ill. Am J Psychiatry 1997;154(5):674-676.

  18. Jefford M, Mileshkin L, Richards K, Thomson J et al. Rapid screening for depression--validation of the Brief Case-Find for Depression (BCD) in medical oncology and palliative care patients. Br J Cancer 2004;91:900-906.

  19. Kawase E, Karasawa K, Shimotsu S, Imasato S et al. Evaluation of a one-question interview for depression in a radiation oncology department in Japan. Gen Hosp Psychiatry 2006;28:321-322.

  20. Lloyd-Williams M, Dennis M, Taylor F, Baker I. Is asking patients in palliative care, “are you depressed?” Appropriate? Prospective study. BMJ 2003;327:372-373.

  21. Meyer HA, Sinnott C, Seed PT. Depressive symptoms in advanced cancer. Part 1. Assessing depression: the Mood Evaluation Questionnaire. Palliat Med 2003;17:596-603.

  22. Ohno T, Noguchi W, Nakayama Y, Kato S et al. How do we interpret the answer “Neither” when physicians ask patients with cancer “Are you depressed or not?”. J Palliat Med 2006;9:861-865.

  23. Payne A, Barry S, Creedon B, Stone C et al. Sensitivity and specificity of a two-question screening tool for depression in a specialist palliative care unit. Palliat Med 2007;21:193-198.

  24. Noguera A, Centeno C, Carvajal A, Tejedor MA et al. Spanish “fine tuning” of language to describe depression and anxiety. J Palliat Med 2009;12:707-12, doi: 10.1089/jpm.2009.0024.

  25. Love AW, Grabsch B, Clarke DM, Bloch S et al. Screening for depression in women with metastatic breast cancer: a comparison of the Beck Depression Inventory Short Form and the Hospital Anxiety and Depression Scale. Aust N Z J Psychiatry 2004;38(7):526-531.

  26. Hopko DR, Bell JL, Armento ME, Robertson SM et al. The phenomenology and screening of clinical depression in cancer patients. J Psychosoc Oncol 2008;26:31-51.

  27. Katz MR, Kopek N, Waldron J, Devins GM et al. Screening for depression in head and neck cancer. Psychooncology 2004;13:269-280.

  28. Lloyd-Williams M, Friedman T, Rudd N. Criterion validation of the Edinburgh postnatal depression scale as a screening tool for depression in patients with advanced metastatic cancer. J Pain Symptom Manage 2000;20(4):259-265.

  29. Lloyd-Williams M, Riddleston H. The stability of depression scores in patients who are receiving palliative care. J Pain Symptom Manage 2002;24:593-597.

  30. Lloyd-Williams M, Shiels C, Dowrick C. The development of the Brief Edinburgh Depression Scale (BEDS) to screen for depression in patients with advanced cancer. J Affect Disord 2007;99:259-264.

  31. Hopwood P, Howell A, Maguire P. Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two selfreport questionnaires. Br J Cancer 1991;64:353-356.

  32. Le Fevre P, Devereux J, Smith S, Lawrie SM et al. Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12. Palliat Med 1999;13:399-407.

  33. Lloyd-Williams M, Friedman T, Rudd N. An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage. 2001;22:990-996.

  34. Mystakidou K, Tsilika E, Parpa E, Katsouda E et al. The Hospital Anxiety and Depression Scale in Greek cancer patients: psychometric analyses and applicability. Support Care Cancer 2004;12:821-825.

  35. Ozalp E, Soygür H, Cankurtaran E, Turhan L et al. Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests. Psychooncology 2008;17:668- 675.

  36. Mitchell AJ, Meader N, Symonds P. Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis. J Affect Disord 2010;126:335-348.

  37. Meyer HA, Sinnott C, Seed PT. Depressive symptoms in advanced cancer. Part 2. Depression over time; the role of the palliative care professional. Palliat Med 2003;17:604-607.

  38. Olden M, Rosenfeld B, Pessin H, Breitbart W. Measuring depression at the end of life: is the Hamilton Depression Rating Scale a valid instrument? Assessment 2009;16:43-54. doi: 10.1177/1073191108320415.

  39. Alfaro-Ramírez del Castillo OI, Morales-Vigil T, Vázquez-Pineda F, Sánchez-Román S et al. Sobrecarga, ansiedad y depresión en cuidadores primarios de pacientes con dolor crónico y terminales. Rev Med Inst Mex Seguro Soc 2008;46(5):485-494.

  40. Landa-Ramírez E, Pérez-Sánchez IN, Sánchez-Román S, Covarrubias A. Ansiedad y depresión relacionadas con presencia e intensidad de síntomas físicos en pacientes con cáncer terminal. Psicología Salud 2014;24:55-63.

  41. López-Alvarenga JC, Vázquez-Velázquez V, Arcila-Martínez D, Sierra- Ovando AE et al. Exactitud y utilidad diagnóstica del hospital anxiety and Depression Scale (HAD) en una muestra de sujetos obsesos mexicanos. Rev Invest Clin 2002;54:403-409.

  42. Torres Vigil I, Aday LA, De Lima L, Cleeland CS. What predicts the quality of advanced cancer care in Latin America? A look at five countries: Argentina, Brazil, Cuba, Mexico, and Peru. J Pain Symptom Manage 2007;34:315-327.

  43. Pastrana T, Vallath N, Mastrojohn J, Namukwaya E et al. Disparities in the contribution of low- and middle-income countries to palliative care research. J Pain Symptom Manage 2010;39:54-68. doi: 10.1016/j.jpa insymman.2009.05.023.

  44. Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol 2013;14:391-436. doi: 10.1016/S1470-2045(13)70048-2.

  45. López Bermúdez MA, Ferro García R, Valero Aguayo L. Intervención en un trastorno depresivo mediante la psicoterapia analítica funcional. Psicothema 2010;22:92-98.

  46. Kempton MJ, Salvador Z, Munafò MR, Geddes JR et al. Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry 2011;68:675- 90. doi: 10.1001/archgenpsychiatry.2011.60.

  47. Papakostas GI, Shelton RC, Kinrys G, Henry ME et al. Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol Psychiatry 2013;18:332-9. doi: 10.1038/mp.2011.166.




2020     |     www.medigraphic.com